SuperSonic Imagine : SuperSonic Imagine Announces a Significant Financing Round -- 28 Million Euros Raised -- FSI Subscribes to

SuperSonic Imagine : SuperSonic Imagine Announces a Significant Financing Round 
-- 28 Million Euros Raised -- FSI Subscribes to Half
the Round Alongside Historical Investors and Two New Arrivals 
PARIS -- (Marketwired) -- 04/02/13 --  SuperSonic Imagine, a French
ultrasound company, is pleased to announce that it has raised EUR 28
million with EUR 14 million invested by the FSI (French Investment
Fund) alongside two new investors, Alto Invest and KLSC (Kuwait Life
Sciences Company) and a substantial subscription from the company's
historical investors. 
Edmond de Rothschild Investment Partners, Auriga Partners, Omnes
Capital (formerly Credit Agricole Private Equity), CDC Entreprises,
NBGI Ventures, Wellington Partners, iXO Private Equity, and Merieux
Developpement, along with Alto Invest and KLSC, are subscribing to
EUR 14 million. 
SuperSonic Imagine will invest the funds to accelerate international
sales and marketing of its Aixplorer(R) ultrasound device, a product
which originally targeted women's health when it was launched in
2009, but which now covers all fields of general radiology, with
regulatory approval in all key international markets. 
Aixplorer's competitive advantages include exceptional image quality
and unique technologies such as: ShearWave(TM) Elastography and
UltraFast(TM) Doppler. ShearWave Elastography is the only modality
available on any ultrasound product which is able to detect tissue
stiffness in a reproducible and quantifiable manner. UltraFast
Doppler, is unique in its ability to image blood flow up to ten times
faster than conventional color Doppler. This not only provides more
reliable diagnoses for the patient but it also significantly
accelerates workflow for the practitioner.  
As a result of the expansion of its addressable market, SuperSonic
Imagine registered strong growth in 2012 with a turnover of EUR 14
million, up 40% from the previous year, 80% of which came from
international. 
"Currently certified in 54 countries and with more than 500 units
sold around the globe, Aixplorer is a worldwide success. This new
injection of funds will allow us to take a leap forward in our
commercial development with a particular focus on the booming Chinese
market," explained Jacques Souquet, founder and CEO of Super
Sonic
Imagine. 
"The FSI sees SuperSonic Imagine as a company with considerable
potential for growth based on revolutionary technological innovation
that had its origins from a successful technology transfer from top
research institutions into a great start up company. The FSI is
pleased to provide SuperSonic Imagine the funding it needs to pursue
both its business and scientific development worldwide," said Mailys
Ferrere, Director of Investment at the FSI and member of the FSI
Executive Board. 
Claude Cohen-Bacrie Executive VP & CTO of SuperSonic Imagine added
that "This investment will help us remain at the forefront of
scientific and technical innovation and affirm our clinical position
through new research."  
Currently, there is data from more than fifty clinical trials that
prove the benefits of ShearWave Elastography in improving ultrasound
diagnoses for various diseases including breast cancer, prostate
cancer, chronic liver disease, muscular disorders, thyroid nodules,
and many more. 
Abdominal, gynecological and pediatric imaging are also available on
the Aixplorer, and the results appear very promising. 
Vascular imaging, launched in 2011 with UltraFast Doppler, has also
been very successful. Aixplorer's UltraFast Doppler is the only
Doppler able to combine Color Flow Imaging with Pulsed Wave Doppler
in a single ultrasound mode. The technology produces a complete
vascular analysis in just a few seconds with an unrivalled level of
detail, improving the examination procedure and providing more
reliable diagnoses. 
Gordon Waldron, Executive VP and CFO of SuperSonic Imagine, is
pleased with this new investment which is among the most significant
private fundings in the French healthcare sector in recent years. He
added, "Since inception, we have been primarily R&D focussed as
SuperSonic brought the first innovation to the ultrasound space in
the past 20 years. Aixplorer has now become a mature system with a
range of applications that meet the needs of both general imaging
experts and their patients. Consequently, we will use these proceeds
to increase our sales and marketing footprint as we enter the growth
and execution phase of our development >>.  
About SuperSonic Imagine -www.supersonicimagine.com
 Founded in 2005
and based in Aix-en-Provence (France), SuperSonic Imagine is an
innovative, international company specializing in ultrasound medical
imaging. The company designs, develops, and markets a revolutionary
ultrasound system, Aixplorer(R), with a unique ultrasound imaging
technology, called MultiWave(TM) Technology. This technology allows
Aixplorer(R) to be the only ultrasound system that images two types
of waves to better characterize tissue; an ultrasound wave to ensure
impeccable image quality and a shear wave, ShearWave(TM)
Elastography, to compute and display true tissue stiffness in real
time by acquiring images nearly 200 times faster than conventional
systems. 
In 2009, SuperSonic Imagine was granted 510(k) clearance by the Food
and Drug Administration in the United States and CE mark in Europe
for the marketing of Aixplorer(R). Distribution agreements have been
signed with prestigious companies such as Hologic (NASDAQ: HOLX) for
the breast market in the U.S.A. and Canon (NYSE: CAJ) for Japan.
SuperSonic Imagine's distribution network has now more than 35
partners worldwide. 
About French Investment Fund
 FSI is a public limited company, 51%
held by The Caisse des Depots group, and 49% held by The French
State. As a prudent investor, FSI holds a minority stake into French
private companies that build valuable and competitive strategies
increasing French business opportunities. 
More information to come on www.fonds-fsi.fr 
About BPI France
 OSEO, CDC Entreprises and French Investment Fund
will go forward as a single company, BPI France, known as French
Public Investment Bank, as soon as merger requirements, such as
European Commission Compliance and Regulation, will be fully
integrated. This institution will offer a broad range of funding
solutions, debt instruments as well as equity's, not only dedicated
to SMEs and innovative companies but also to large-scale companies
that foster French economic growth from a strategic perspective. 
More information to come on www.bpifrance.fr 
About ALTO INVEST - www.altoinvest.fr
 ALTO INVEST is an independent
management company dedicated to investments in SMEs. ALTO INVEST
manages over EUR 300 million in retail and institutional funds (FCPI,
FIP and FCPR), invested in more than 100 European innovation-rich
companies representing a total turnover of EUR 6 billion and 40,000
employees.  
Alto Invest is fully approved by the French financial authorities
(Autorite des Marches Financiers) and is an active member of the
French Asset Management Association (Association Francaise de la
Gestion Financiere). 
About KLSC
 Kuwait Life Sciences Company (KLSC) is fully owned by
National Technology Enterprises Company (NTEC); a Kuwait Investment
Authority (KIA) fully owned company. KLSC aims to accelerate the
transfer of best in-class technologies and innovative business models
practiced globally to match the needs of Kuwait & the region, in
addition to offering healthcare professionals with distinguished
opportunities for development and growth that match international
standards. To achieve this, KLSC looks for investment opportunities
in the areas of medical technology, diagnostics, pharmaceuticals and
healthcare services which address prevalent diseases in the MENA
region. KLSC also has a distribution arm to commercialize innovative
medical technologies mainly in laboratory diagnostics, surgical &
Imaging, mobile Health and screening programs. With regards to
professional development, KLSC has established the first healthcare
academy in the GCC region offering continuous medical education
programs across all healthcare sectors.  
For further information, visit the KLSC website at www.klsc.com.kw 
Press contacts 
SuperSonic Imagine
Michele Debain
Global Marketing Director
michele.debain@supersonicimagine.fr
+33 (0)4 42 99 24 32 
FSI :
Anne Descamps
Havas Worldwide
+33 (0)1 58 47 93 32
anne.descamps@havasww.com 
H&B Communication
Florence Portejoie
f.portejoie@hbcommunication.fr
+33 (0)1 58 18 32 58 
+33 (0)6 88 84 81 74 
Elise Hermant
Havas Worldwide
+33 (0)1 58 47 84 09
elise.hermant@havasww.com 
Anne Hardy
a.hardy@hbcommunication.fr
+33 (0)1 58 18 32 51 
+33 (0)6 13 56 23 96 
Alto Invest :
Samuel Beaupain
Edifice
+33 (0)1 80 81 50 05
samuelbeaupain@reseau-edifice.com 
KLSC
Fatma AlGharabally
Investment Manager
Tel:(+965) 22 49 09 69
Cell: (+965) 99 44 50 80 
Press release
http://hugin.info/156436/R/1689673/554617.pdf